Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia × Educational Status × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Prostatic Neoplasms 4 Obesity-Related Malignant Neoplasm 3 Neoplasm Metastasis 3 Lymphoma 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Papillomavirus Infections 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 HIV Infections 1 Glioblastoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

venetoclax 15 Cyclophosphamide 13 Cytarabine 7 fludarabine 6 Azacitidine 6 ruxolitinib 5 fludarabine phosphate 5 Rituximab 5 Whole-Body Irradiation 4 Mycophenolic Acid 4 Mesna 4 Melphalan 4 Decitabine 4 revumenib 3 ibrutinib 3 Vincristine 3 Tacrolimus 3 Peripheral Blood Stem Cell Transplantation 3 Methotrexate 3 Mercaptopurine 3 Dexamethasone 3 Daunorubicin 3 Dasatinib 3 Busulfan 3 Bone Marrow Transplantation 3 quizartinib 2 ponatinib 2 pembrolizumab 2 pegaspargase 2 obinutuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡